If it was a few of only many, then why did their warning mention only
one case (not a few), and qualify it as a 'possible' case? If a small
trial of a few thousand patients produced 1 case of SJS, then given
the estimated millions of modafinil users since, there ought to be
more than that...
--
gwern
http://www.gwern.net
If anyone cares, modafinil is an interest of mine and I keep a
collection of online sources:
http://www.gwern.net/Modafinil#suppliers-prices
There's also modafinil on Silk Road, but all the sellers seem to
expect a lot for it.
--
gwern
http://www.gwern.net
--
You received this message because you are subscribed to the Google Groups "Dual N-Back, Brain Training & Intelligence" group.
To post to this group, send email to brain-t...@googlegroups.com.
To unsubscribe from this group, send email to brain-trainin...@googlegroups.com.
For more options, visit this group at http://groups.google.com/group/brain-training?hl=en.
True enough. I mention explicitly that Airsealed seems to be getting
out of modafinil, and there have been various broken links and dead
sites in the past year. (No idea when you used the list.)
> furthermore, i believe Jonathan told me that thepharmacyexpress did
> not deliver, refused to answer emails, etc, months of trying.
What he told me was that he had ordered from EDAndMore; he canceled
his order and got a refund. He mentioned his order had come in 3 days
previously from The Pharmacy Express; he did not mention any concerns
about the TPE modafinil being fake.
> so what is a good source on Gwern's site is unknown, esp. when you
> factor in the fact that i just watched something on the news over here
> wherein they determined that approximately 50% of online drugs were
> counterfeit--fakes--resulting in the death of some, and the harm of
> others (some ppl had paid a doctor for botox, and the doctor used an
> online source, and their faces were grossly deformed, they were placed
> on ventilators in the icu for a couple weeks, were paralyzed for
> awhile, etc etc)
Well, to some extent you can deal with that problem by sending the
product to a lab. I recently learned of a testing service run by
Erowid (see http://www.gwern.net/Modafinil#assaying ) which will tell
you whether modafinil was present or not in a pill (but not its
concentration or whether there are any other problems with the pill
like heavy metals).
--
gwern
http://www.gwern.net
If you look at the relevant section of the prescribing material:
> In clinical trials of modafinil, the incidence of rash resulting in discontinuation was approximately 0.8%
(13 per 1,585) in pediatric patients (age <17 years); these rashes
included 1 case of possible Stevens-
Johnson Syndrome (SJS) and 1 case of apparent multi-organ
hypersensitivity reaction. Several of the cases
were associated with fever and other abnormalities (e.g., vomiting,
leukopenia). The median time to rash that
resulted in discontinuation was 13 days. No such cases were observed
among 380 pediatric patients who
received placebo. No serious skin rashes have been reported in adult
clinical trials (0 per 4,264) of modafinil.
Rare cases of serious or life-threatening rash, including SJS, Toxic
Epidermal Necrolysis (TEN), and Drug Rash
with Eosinophilia and Systemic Symptoms (DRESS) have been reported in
adults and children in worldwide
post-marketing experience. The reporting rate of TEN and SJS
associated with modafinil use, which is
generally accepted to be an underestimate due to underreporting,
exceeds the background incidence rate.
Estimates of the background incidence rate for these serious skin
reactions in the general population range
between 1 to 2 cases per million-person years.
As I previously said, that SJS case was and apparently remains
unconfirmed. Notice that in the previous adult trial, with ~3x as many
patients, no rashes whatsoever were reported and certainly no SJS.
With a background incidence rate of 1 to 2 cases per
million-person-years, to be distinguishable, the rate would only have
to rise a little. Too bad they don't tell us exactly how many but
given the reporting biases at play (both for and against reporting),
perhaps the FDA doesn't permit more details; for example, I'd
especially want to know whether those 'adults and children' is really
just 'children'. As it stands, it looks like the problem is primarily
in juveniles.
(Page 4 also seems to imply that those pediatric trials were being
conducted on kids with ADHD. Important? Dunno.)
> Regarding vasodilitation in 1 out of 50, this appears in Cephalon's
> physician Prescribing Notes. See Table 3 Emergent side effects,
> showing 2% level of occurrence vs. 0% for placebo. I have always found
> it remarkable that vasodilatation was even identifiable and in my
> opinion it is used as medical code for the more known term,
> hypotension.
>
> http://www.provigil.com/media/PDFs/prescribing_info.pdf
I'm more amused by how the vasodilation/hypotension increase to 2% of
patients is exactly matched by an increase in hypertension from 1% to
3%. (Modafinil! It does stuff to blood pressure! But don't ask me
what.)
--
gwern
http://www.gwern.net